今开:1.98 | 昨收:1.84 |
最高:1.98 | 最低:1.8227 |
涨停价:0.0 | 跌停价:0.0 |
总市值:7.040265E7 |
Scynexis(SCYX)02-14 05:35
$Scynexis(SCYX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000935836-24-000141 Act: 34 Size: 59 KB 网页链接查看全文
Scynexis(SCYX)04-26 04:45
$Scynexis(SCYX)$ DEF 14A Other definitive proxy statements Accession Number: 0001140361-24-022086 Act: 34 Size: 2 MB 网页链接查看全文
Scynexis(SCYX)04-26 04:45
$Scynexis(SCYX)$ ARS Annual Report to Security Holders Accession Number: 0001140361-24-022094 Act: 34 Size: 682 KB 网页链接查看全文
Scynexis(SCYX)05-09 04:05
$Scynexis(SCYX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-055590 Act: 34 Size: 8 MB 网页链接查看全文
Scynexis(SCYX)02-17 06:55
$Scynexis(SCYX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-016578 Size: 4 KB 网页链接查看全文
Scynexis(SCYX)02-14 09:45
$Scynexis(SCYX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000919574-24-001218 Act: 34 Size: 201 KB 网页链接查看全文
Scynexis(SCYX)03-29 04:25
$Scynexis(SCYX)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-038046 Act: 34 Size: 12 MB 网页链接查看全文
Scynexis(SCYX)02-10 06:15
$Scynexis(SCYX)$ 144 Report of proposed sale of securities Accession Number: 0001623632-24-000234 Act: 33 Size: 6 KB 网页链接查看全文
Scynexis(SCYX)02-14 10:15
$Scynexis(SCYX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000919574-24-001223 Act: 34 Size: 125 KB 网页链接查看全文
Scynexis(SCYX)03-29 04:15
$Scynexis(SCYX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-038015 Act: 34 Size: 400 KB 网页链接查看全文
智通财经APP讯,翰森制药(03692)公布,于2021年2月11日,翰森(上海)健康科技有限公司及江苏豪森药业集团有限公司(统称为“被许可人”,各自为该公司的全资附属公司)已与SCYNEXIS, Inc.(纳斯达克股份代号:SCYX)订立独家许可及合作协议。... 网页链接
$Scynexis(SCYX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-055590 Act: 34 Size: 8 MB 网页链接
$Scynexis(SCYX)$ DEF 14A Other definitive proxy statements Accession Number: 0001140361-24-022086 Act: 34 Size: 2 MB 网页链接
$Scynexis(SCYX)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001140361-24-022093 Act: 34 Size: 7 MB 网页链接
$Scynexis(SCYX)$ ARS Annual Report to Security Holders Accession Number: 0001140361-24-022094 Act: 34 Size: 682 KB 网页链接
$Scynexis(SCYX)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0000950170-24-038086 Act: 33 Size: 193 KB 网页链接
$Scynexis(SCYX)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-038046 Act: 34 Size: 12 MB 网页链接
$Scynexis(SCYX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-038015 Act: 34 Size: 400 KB 网页链接
$Scynexis(SCYX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-016578 Size: 4 KB 网页链接
$Scynexis(SCYX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000919574-24-001223 Act: 34 Size: 125 KB 网页链接
$Scynexis(SCYX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000919574-24-001218 Act: 34 Size: 201 KB 网页链接